Transcriptional abnormalities in Huntington disease - PubMed
Review
Transcriptional abnormalities in Huntington disease
Katharine L Sugars et al. Trends Genet. 2003 May.
Abstract
Huntington disease (HD) is caused by a CAG repeat expansion that is translated into an abnormally long polyglutamine (polyQ) tract in the huntingtin protein. The precise mechanisms leading to neurodegeneration in HD have not been fully elucidated, but alterations in gene transcription could well be involved because the activities of several nuclear proteins are compromised by the polyQ mutation. Recent microarray studies also show relevant changes in gene expression profiles in HD models, providing useful information on the potential consequences of disrupted transcriptional pathways in HD.
Similar articles
-
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM, Young AB, Tanese N, Krainc D. Dunah AW, et al. Science. 2002 Jun 21;296(5576):2238-43. doi: 10.1126/science.1072613. Epub 2002 May 2. Science. 2002. PMID: 11988536
-
Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, Kato K, Rubinsztein DC. Wyttenbach A, et al. Hum Mol Genet. 2001 Aug 15;10(17):1829-45. doi: 10.1093/hmg/10.17.1829. Hum Mol Genet. 2001. PMID: 11532992
-
How does the Huntington's disease mutation damage cells?
Rubinsztein DC. Rubinsztein DC. Sci Aging Knowledge Environ. 2003 Sep 17;2003(37):PE26. doi: 10.1126/sageke.2003.37.pe26. Sci Aging Knowledge Environ. 2003. PMID: 13679594 Review.
-
Lessons from animal models of Huntington's disease.
Rubinsztein DC. Rubinsztein DC. Trends Genet. 2002 Apr;18(4):202-9. doi: 10.1016/s0168-9525(01)02625-7. Trends Genet. 2002. PMID: 11932021 Review.
-
Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, MacDonald ME, Gusella JF. Huang CC, et al. Somat Cell Mol Genet. 1998 Jul;24(4):217-33. doi: 10.1023/b:scam.0000007124.19463.e5. Somat Cell Mol Genet. 1998. PMID: 10410676
Cited by
-
The promise and perils of HDAC inhibitors in neurodegeneration.
Didonna A, Opal P. Didonna A, et al. Ann Clin Transl Neurol. 2015 Jan;2(1):79-101. doi: 10.1002/acn3.147. Epub 2014 Dec 3. Ann Clin Transl Neurol. 2015. PMID: 25642438 Free PMC article. Review.
-
Lee J, Hong YK, Jeon GS, Hwang YJ, Kim KY, Seong KH, Jung MK, Picketts DJ, Kowall NW, Cho KS, Ryu H. Lee J, et al. Cell Death Differ. 2012 Jul;19(7):1109-16. doi: 10.1038/cdd.2011.196. Epub 2012 Jan 13. Cell Death Differ. 2012. PMID: 22240898 Free PMC article.
-
Jia H, Kast RJ, Steffan JS, Thomas EA. Jia H, et al. Hum Mol Genet. 2012 Dec 15;21(24):5280-93. doi: 10.1093/hmg/dds379. Epub 2012 Sep 10. Hum Mol Genet. 2012. PMID: 22965876 Free PMC article.
-
Wang JQ, Chen Q, Wang X, Wang QC, Wang Y, Cheng HP, Guo C, Sun Q, Chen Q, Tang TS. Wang JQ, et al. J Biol Chem. 2013 Feb 1;288(5):3070-84. doi: 10.1074/jbc.M112.407726. Epub 2012 Dec 17. J Biol Chem. 2013. PMID: 23250749 Free PMC article.
-
Pal A, Severin F, Lommer B, Shevchenko A, Zerial M. Pal A, et al. J Cell Biol. 2006 Feb 13;172(4):605-18. doi: 10.1083/jcb.200509091. J Cell Biol. 2006. PMID: 16476778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases